Official GMP audit in Japan

2012-07-18

　　The Japan Medicines and Medical Machinery Agency (PMDA) conducted an on-site GMP compliance inspection of our company's irinotecan hydrochloride from May 18 to May 20, 2010. One month later, we received formal notification from PMDA that the production and inspection of Sichuan Xieli Pharmaceutical's Illitacan Hydrochloride API met GMP requirements

2026-10-17

Concluded with Distinction in Milan • Successfully Passed E...

2026-09-22

Craftsmanship of Xieli, New‑start in the Greater Bay Area |...

2026-08-28

Ingenuity in Plant‑derived Extracts, Powering Global Expans...

2026-07-09

Good News | Sichuan Xieli Pharmaceutical Awarded EcoVadis Br...

2026-06-17

New CEP Certificate Granted – Ursodeoxycholic Acid Hits New...